Vitestro Achieves CE Marking for Autonomous Blood Drawing Device
UTRECHT, Netherlands, Aug. 28, 2024 /PRNewswire/ — Vitestro, a pioneer in the field of medical robotics, is proud to announce that its innovative automated blood drawing device has received CE marking. This marks a significant milestone for the company, acknowledging... Read More →
Two New FDA-Clearances for Sibel Health Enables Compatibility of Advanced Wearable Sensors to 3rd Party Software Solutions
CHICAGO, Aug. 22, 2024 /PRNewswire/ — Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible third party software applications. In order to democratize vital signs globally, Sibel Health is committed to enabling widespread access... Read More →
Universal DX Initiates Clinical Trial for FDA Approval of Signal-C® Colorectal Cancer Screening Blood Test
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Universal DX (“UDX”), a biotech company dedicated to transforming cancer into a curable disease by detecting it early, today announced closure of the Series B which funds the clinical trial for its colorectal cancer screening blood test, Signal-C®,... Read More →
Precision oncology startup 4baseCare raises $6 million in funding
4baseCare, a Bengaluru-based healthcare startup focused on precision oncology, has raised $6 million in a Series A funding round led by Yali Capital, with participation from other investors. The startup will use the raised capital to enhance its product offerings... Read More →
CRISPR QC Launches Three Innovative Products and Unveils Revamped Website
SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a pioneering biotechnology company in San Diego, is excited to announce the launch of several groundbreaking products designed to revolutionize the field of gene editing. These products, part of the CRISPR Analytics Platform, provide comprehensive insights... Read More →
PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer
AUSTIN, Texas–(BUSINESS WIRE)–PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company redefining cancer treatment with therapeutics administered continuously and exclusively at the tumor site, today announced the U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug... Read More →
Singapore medtech startup raises US$7 million to expand accessible respiratory care globally
Aevice Health provides one of the first remote patient monitors designed for those with chronic respiratory disease SINGAPORE-BASED digital health company Aevice Health has secured US$7 million in a seed plus round to expand its operations in the US, Japan... Read More →
CroíValve raises $16m in Series B for heart valve treatment device
The funding will finance an early feasibility study of its flagship product Duo to evaluate its safety and performance in treating tricuspid regurgitation. CroíValve, a medtech start-up that spun out of Trinity College Dublin, has closed a $16m Series B... Read More →
Wellinks Integrates Virtual Pulmonary Rehabilitation Program at UMass Memorial Health for Massachusetts Residents Living with COPD
NEW HAVEN, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) — Wellinks, a digital healthcare company offering comprehensive value-based solutions for Chronic Obstructive Pulmonary Disease (COPD) management, today announced plans to integrate its pulmonary rehabilitation program at UMass Memorial Health (UMMH) to... Read More →
Prana Thoracic Completes Series A Extension of $3 Million in Oversubscribed Round, Bringing Total Funding to $9 Million
HOUSTON–(BUSINESS WIRE)–Prana Thoracic, a Houston-based medtech startup, founded with a vision to transform lung cancer intervention, proudly announces the successful final closing of its Series A extension round. The company initially raised $3M, received a non-dilutive grant of $3M, and... Read More →